India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

India Juris gets CIRP of Angle Infrastructure admitted

In $4.2 mn. Series A round of WeVois, IJ represents one of the Invstt Trust

IJ represents Invstt Trust in $1.2 million in seed funding round of Greenstitch

Publications

Dissecting the Order passed by CCI against Goldman Sachs (India) Alternative Investment Management Pvt. Ltd.

Patent & Trademark Guide in India

Registration of Foreign Portfolio Investors in India

Newsletters

Relaxation in Timelines for AIFs’ Investments in Demat Form

FAQs on IFSCA (Setting up & operation of IBC and OEC) Regulations, 2022

Liquidity Enhancement Scheme for Bullion Exchange